Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Melanoma × Immunotherapy × Clear all

Phase

Status

Recruiting 5 Completed 5 Terminated 2 Active not recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Lung Diseases 1 Locally Advanced Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Nivolumab 15 Ipilimumab 13 pembrolizumab 8 trametinib 7 Cyclophosphamide 7 dabrafenib 6 Radiotherapy 5 Interleukin-2 5 sargramostim 4 aldesleukin 4 Vemurafenib 4 130-nm albumin-bound paclitaxel 4 Specimen Handling 3 Radiosurgery 3 Melphalan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 fludarabine 2 encorafenib 2 binimetinib 2 Magnetic Resonance Spectroscopy 2 Introns 2 Infliximab 2 CTLA-4 Antigen 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 yeast-CEA vaccine 1 vitespin 1 vedolizumab 1 urelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04242329 2024-01-26

SUMMIST

Vastra Gotaland Region

Phase 2 Withdrawn

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡